Corine C. Visser

Targeting liposomes with protein drugs to the blood–brain barrier in vitro

Corine C. Visser, Sanja Stevanović, L. Heleen Voorwinden et al. · European Journal of Pharmaceutical Sciences · 2005 · 115 citations

Pharmacy, Pharmaceutics, Pharmacology +14

Validation of the Transferrin Receptor for Drug Targeting to Brain Capillary Endothelial Cells<i>In Vitro</i>

Corine C. Visser, Sanja Stevanović, L. Heleen Voorwinden et al. · Journal of drug targeting · 2004 · 95 citations

Pharmacy, Cell Biology, Pharmaceutics +17

Characterization and Modulation of the Transferrin Receptor on Brain Capillary Endothelial Cells

Corine C. Visser, L. Heleen Voorwinden, Daan J.A. Crommelin et al. · Pharmaceutical Research · 2004 · 75 citations

Life Sciences, Cell Biology, Physiology +14

Differential effects of the allosteric enhancer (2-amino-4,5-dimethyl-trienyl)[3-(trifluoromethyl) phenyl]methanone (PD81,723) on agonist and antagonist binding and function at the human wild-type and a mutant (T277A) adenosine A1 receptor11Abbreviations: CCPA, 2-chloro-N6-cyclopentyladenosine; DPCPX, 1,3-dipropyl-8-cyclopentylxanthine; CPA, N6-cyclopentyladenosine, R-PIA, N6-[-(R)-1-methyl-2-phenylethyl]adenosine; NECA, 5′-(N-ethyl)-carboxamidoadenosine; N-0840, N6-cyclopentyl-9-methyladenine; theophylline, 1,3-dimethylxanthine; PD81,723, (2-amino-4,5-dimethyl-trienyl)[3-(trifluoromethyl) phenyl]methanone; BCA, bicinchoninic acid; BCS, bovine calf serum; cAMP, adenosine 3′,5′-cyclic monophosphate; DMEM, Dulbecco’s modified Eagle’s medium; CHO, Chinese hamster ovary; and wt, wild-type.

Angeliki P. Kourounakis, Corine C. Visser, Miriam de Groote et al. · Biochemical Pharmacology · 2001 · 49 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Enhanced brain drug delivery: safely crossing the blood–brain barrier

Pieter J. Gaillard, Corine C. Visser, Chantal C.M. Appeldoorn et al. · Drug Discovery Today Technologies · 2011 · 45 citations

Pharmacy, Pharmaceutics, Pharmacology +14